You are here » Home » Companies » Company Overview » Gufic BioSciences Ltd

Gufic BioSciences Ltd.

BSE: 509079 Sector: Health care
NSE: GUFICBIO ISIN Code: INE742B01025
BSE LIVE 15:40 | 07 Dec 46.50 0.60
(1.31%)
OPEN

46.60

HIGH

47.80

LOW

46.00

NSE LIVE 15:54 | 07 Dec 46.60 0.55
(1.19%)
OPEN

46.35

HIGH

48.00

LOW

45.70

OPEN 46.60
PREVIOUS CLOSE 45.90
VOLUME 12382
52-Week high 62.00
52-Week low 33.30
P/E 36.61
Mkt Cap.(Rs cr) 359.91
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 46.60
CLOSE 45.90
VOLUME 12382
52-Week high 62.00
52-Week low 33.30
P/E 36.61
Mkt Cap.(Rs cr) 359.91
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Gufic BioSciences Ltd.

Gufic BioSciences Ltd

Gufic Biosciences (GBL) is a result of a reverse merger of itself with Central Finance. The promoters of GBL took over Central Finance at Rs 40-42 per share and then got GBL listed on BSE. The Choksi and Gandhi family, the promoters of GBL, have a long-standing presence in the pharma industry. In 1960, the family set up a joint venture company called Lyka Labs. In 1976, they decided to part way...> More

Gufic BioSciences Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   360
EPS - TTM () [*S] 1.27
P/E Ratio (X) [*S] 36.61
Face Value ()   1
Latest Dividend (%)   5.00
Latest Dividend Date 19 Sep 2016
Dividend Yield (%) 0.11
Book Value / Share () [*S] 5.06
P/B Ratio () [*S] 9.19
[*C] Consolidated     [*S] Standalone

Gufic BioSciences Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 64.39 51.42 25.22
Other Income 0.06 0.33 -81.82
Total Income 64.45 51.75 24.54
Total Expenses 57.87 46.97 23.21
Operating Profit 6.57 4.78 37.45
Net Profit 2.64 1.65 60
Equity Capital 7.74 7.74 -
> More on Gufic BioSciences Ltd Financials Results

Gufic BioSciences Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Anuh Pharma 209.85 -0.52 525.88
Themis Medicare 580.10 -2.41 523.83
Lincoln Pharma. 191.15 -1.21 382.30
Gufic BioScience 46.50 1.31 359.91
Medicamen Biotec 257.30 -2.76 270.68
Orchid Pharma 28.95 -1.03 257.54
Jenburkt Pharma 522.05 0.87 242.75
> More on Gufic BioSciences Ltd Peer Group

Gufic BioSciences Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 69.98
Banks/FIs 0.02
FIIs 0.37
Insurance 0.00
Mutual Funds 0.00
Indian Public 15.55
Custodians 0.00
Other 14.09
> More on Gufic BioSciences Ltd Share Holding Pattern

Gufic BioSciences Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -2.41% -2.41% -1.56% -1.49%
1 Month -6.16% -5.95% -4.45% -4.65%
3 Month 20.31% 20.41% -9.30% -9.15%
6 Month 13.41% 13.52% -2.86% -1.99%
1 Year -20.92% -20.75% 2.77% 4.34%
3 Year 701.72% 703.45% 24.96% 29.43%

Gufic BioSciences Ltd - STOCK STRENGTH

Today's Low/High 46.00
47.80
Week Low/High 45.00
49.00
Month Low/High 40.90
53.00
YEAR Low/High 33.30
62.00
All TIME Low/High 0.17
65.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard